APA (7th ed.) Citation

JIANG, N., GE, J., XIAN, Y., HUANG, S., & LI, Y. (2016). Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients. Biomedical Reports, 4(4), 453. https://doi.org/10.3892/br.2016.617

Chicago Style (17th ed.) Citation

JIANG, NIAN-XIN, JUN-WEI GE, YU-QIONG XIAN, SHAO-YING HUANG, and YAN-SONG LI. "Clinical Application of a New Warfarin-dosing Regimen Based on the CYP2C9 and VKORC1 Genotypes in Atrial Fibrillation Patients." Biomedical Reports 4, no. 4 (2016): 453. https://doi.org/10.3892/br.2016.617.

MLA (9th ed.) Citation

JIANG, NIAN-XIN, et al. "Clinical Application of a New Warfarin-dosing Regimen Based on the CYP2C9 and VKORC1 Genotypes in Atrial Fibrillation Patients." Biomedical Reports, vol. 4, no. 4, 2016, p. 453, https://doi.org/10.3892/br.2016.617.